Home/Filings/4/0000950170-25-069633
4//SEC Filing

Kawakami Mark 4

Accession 0000950170-25-069633

CIK 0001469443other

Filed

May 11, 8:00 PM ET

Accepted

May 12, 8:56 PM ET

Size

5.5 KB

Accession

0000950170-25-069633

Insider Transaction Report

Form 4
Period: 2025-05-09
Kawakami Mark
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-05-09+12,50033,987 total
    Exercise: $3.88Exp: 2035-05-09Common Stock (12,500 underlying)
Footnotes (1)
  • [F1]The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.

Documents

1 file

Issuer

Arcadia Biosciences, Inc.

CIK 0001469443

Entity typeother

Related Parties

1
  • filerCIK 0002030709

Filing Metadata

Form type
4
Filed
May 11, 8:00 PM ET
Accepted
May 12, 8:56 PM ET
Size
5.5 KB